Search All News
With $16 million gift, Columbia will open a new center for Lyme and other tick-borne diseases this summer, offering patients specialized care and expanding research at a national level.
A collaboration between Observational Health Data Sciences and Informatics (OHDSI) and Health Level Seven International (HL7) will improve access and sharing of health care data among researchers.
A clinical trial to test a gene therapy for some patients with dry age-related macular degeneration—a leading cause of blindness in the United States—is underway at Columbia and NewYork-Presbyterian.
Spread of a new SARS-CoV-2 variant in the New York City region that shares worrisome similarities with other recent variants has been identified by scientists at Columbia University.
- December 2, 2020
Researchers at Columbia, UCLA, and Northeastern have begun helping the FDA in its effort to monitor the safety and effectiveness of vaccines, including COVID-19 vaccines, and other biologic products.
- December 1, 2020
New findings suggest a hormone called lipocalin-2, previously found to suppress food intake in mice, may also prevent weight gain in humans.
- November 27, 2020
Columbia researchers characterized a new class of ‘biomimetic’ drugs that plug a calcium channel implicated in the development of cancer and several other diseases.
- November 19, 2020
Columbia University COVID researchers are working to improve coronavirus testing, find new antivirals, and develop new ways to prevent transmission.
- November 16, 2020
A new nationwide study of more than 50,000 individuals—coordinated by Columbia researchers—is now underway to determine factors that predict disease severity and long-term health impacts of COVID-19.
- November 12, 2020
Ancient parts of the brain may hold secrets that help explain the drive to eat and how eating may affect brain health. Sabrina Diano, the new Institute of Human Nutrition director, is investigating.
- November 5, 2020
Immunotherapy, often ineffective against stomach cancer, was more effective when combined with chemotherapy and given earlier, finds a new study in mice.
- October 28, 2020
The most detailed analysis to date of CRISPR genome editing in human embryos finds a significant risk of chromosomal abnormalities when using the technique at the earliest stage of human development.
- October 27, 2020
Coronaviruses are adept at mimicking human immune proteins called complement, which may allow the viruses to gain a foothold in our bodies and cause disease.
- October 27, 2020
Columbia/NYSPI researchers are examining how millions of college students are addressing COVID-19 challenges, including academic/life plans, decision-making, substance use, and mental well-being.